Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

8
Apple, Caterpillar Dominate the Dow Friday

2h 247wallst
August 17, 2018: Markets opened mixed Friday but all three major indexes are pointed at a positive close for the day. Sanctions on Iran are said to include penalties as well for countries currently buying oil from the Islamic Republic. That would include China with which the United States is scheduled to begin trade talks next week. All 11 S&P sectors are trading in the green ahead of the close with industrials and consumer staples performing best.
PFZ CATR CAT AAPL CSCO 500680 PFE PFIZER

5
EpiPen shortage has parents struggling during back-to-school season

5h cnbc
Brenda Thiel and Alyssa Wachtler live on opposite sides of the country. But they've got at least one thing in common: both have sons with severe nut allergies. And when they made their usual back-to-school trips to the pharmacy to procure their EpiPens for the new year, they were told the same thing.
WFC WFCNP PFZ PFIZER 500680 PFE

1
Pfizer Limited - Appointment

2018-08-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
PFZ 500680 PFE PFIZER

10
Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

2018-08-15 247wallst
Each month brings new views from firms on Wall Street. This includes the actively followed RIC Report from Merrill Lynch, showing views on many sectors and many markets for the firm’s clients. The monthly RIC Report is quite favorable on the health care sector as an opportunity for investors.
PFZ AMGN MRK A ABBV 500680 PFE PFIZER ABBV

6
Current Bull Market Not Over Until It’s Over: 5 US Stocks to Buy

2018-08-15 247wallst
It may be hard to believe, but on August 23, according to Merrill Lynch, the current bull market will be the longest in history, reaching back to the lows printed in March of 2009. While some would argue that the actual secular bull market didn’t start until the S&P 500 broke out above 1,550 in March of 2013, that in and of itself, was over five years ago.
PFZ C ANAC PFIZER CGBBW 500680 PFE

1
EpiPen shortage could turn into crisis as back-to-school season hits - MarketWatch

2018-08-14 marketwatch
Mylan’s EpiPen was first added to the FDA’s drug shortage list in May, but supply issues continue
PFZ 500680 PFE PFIZER

28
Startups Turning Office Market Upside Down by Offering Short-Term Leases - WSJ

2018-08-14 wsj
A startup real-estate technology firm is looking to take on shared office company WeWork Cos in one of hottest new areas of commercial real estate: providing short-term office space to some of the biggest U.S. companies.
BPY CCV CCZ FMCKI FMCKJ UBS CMCSK IBM H FMCCO PFZ FMCCP FMCCM FMCCN CMCSA FMCCI FMCCJ P FMCCG FMCKO FMCKP FMCKM FMCKN PFIZER FMCKK FMCKL FMCC CCV.CL MSFT 500680 PFE FMCCS ULSGF FMCCT

1
A Quality Driven Dividend Growth Portfolio - Pfizer Inc.

2018-08-13 seekingalpha
This portfolio is about choosing stocks based on a quality metric score and determining whether to buy based on a purchase metric score.
PFZ 500680 PFE PFIZER

17
Shire, Shionogi File NDA for Intuniv for Adults in Japan

2018-08-13 zacks
Shire Plc. (SHPG - Free Report) announced that its Japanese partner Shionogi & Co., Ltd submitted a new drug application (NDA) for the manufacture and marketing of Intuniv (guanfacine hydrochloride extended release) in Japan for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. Intuniv is being co-developed and commercialized by Shire and Shionogi under a licensing contract signed in 2011.
FOX PFZ GILD JNJ LMHA 500680 PFE LMHB FOXA PFIZER LM

1
Generic Drugmakers Struggle Despite U.S. Push for Copycats - Bloomberg

2018-08-09 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
PFZ 500680 PFE PFIZER

34
CEF Opportunity: 5.5% Yield, 20% Upside, Well-Positioned For Rising Rates, Diversified Holdings

2018-08-09 seekingalpha
I love Mario Gabelli. I have been following him from the first time I saw him speak on CNBC. He has a knack for picking great stocks.
CVS HON 8685 STT AVF PNCFO GDV WM AIG PFIZER PNC SWMAF VZ BA PFE WFCNP SWMAY VZA BOE XYL WFC HON PFZ DWDP PEP PNUCL 500680

44
Disney, Pfizer Keep the Dow Flat Wednesday

2018-08-08 247wallst
August 8, 2018: Markets opened narrowly mixed Wednesday and looks set to end the regular trading session the same way. The blue-chip Dow index traded lower all day while the S&P 500 and the Nasdaq Composite are holding onto slim gains. The Trump trade war with China experienced another skirmish yesterday, but corporate earnings reports continue to offset investors’ fears. The energy sector lagged today while the tech and financial services sectors posted the best gains.
PFZ CATR CAT 500680 PFE PFIZER MCD DIS

3
Protagonist Stock Jumps 58% After Re-Review of Test Results

2018-08-08 investorplace
The mouth-watering 58% rise in shares of Protagonist Therapeutics (NASDAQ:PTGX) on Monday should interest biotech investors. The rally is a welcome change after months of PTGX stock going nowhere.
PFZ CELG PTGX 500680 PFE PFIZER

1
UPDATE 1-Trump says will make announcement next week on reducing drug prices

2018-08-08 reuters
BEDMINSTER, N.J. (Reuters) - U.S. President Donald Trump said on Tuesday that his administration would make an announcement next week on reducing drug prices, but he did not offer specifics.
PFZ 500680 PFE PFIZER

6
Zero-Sales Biotechs May Damage Your Financial Health - Bloomberg

2018-08-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK PFZ GSC TFG PFIZER GSJ RHHBF GS GLSSP RHHVF RHHBY BGNE GJS 500680 PFE

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...